Center for Aging, Genetics and Neurodegeneration, Massachusetts General Hospital — Boston, Massachusetts

Center for Aging, Genetics and Neurodegeneration, Massachusetts General Hospital is a clinical research site located in Boston, Massachusetts, United States 02114.

Crixeo Clinical Trials Trust Score: 94/100 (GOOD). This profile has not yet been claimed by the site owner.

Center for Aging, Genetics and Neurodegeneration, Massachusetts General Hospital has participated in 1 clinical trials.

Therapeutic areas: Parkinson Disease.

Sponsors: Cephalon.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Boston

Browse all research sites in Massachusetts · View every site in Boston

Sponsor Feasibility Report

Trust Score: 94/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Center for Aging, Genetics and Neurodegeneration, Massachusetts General Hospital?

Center for Aging, Genetics and Neurodegeneration, Massachusetts General Hospital has a Crixeo Trust Score of 94/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Center for Aging, Genetics and Neurodegeneration, Massachusetts General Hospital conducted?

Center for Aging, Genetics and Neurodegeneration, Massachusetts General Hospital has 1 clinical trials on record. Their work covers Parkinson Disease.

Is Center for Aging, Genetics and Neurodegeneration, Massachusetts General Hospital accredited by Crixeo Clinical Trials?

Center for Aging, Genetics and Neurodegeneration, Massachusetts General Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Center for Aging, Genetics and Neurodegeneration, Massachusetts General Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.